Application number: |
P200200129 |
Patent number: |
05375 |
PCT application number: |
FI00/00761 |
Filing date of the application: |
08.09.2000 |
Publication date: |
15.04.2003 |
Date of the grant of the patent: |
15.02.2011 |
Priority date: |
10.09.1999
|
Estonian title : |
Levosimendani farmatseutiline lahus |
English title : |
Pharmaceutical solution of levosimendan |
Status: |
Patent protection period expired |
Fees paid for the years of validity : |
20 |
IPC class: |
A61K31/501 A61K9/08
|
CPC class: |
|
Estonian abstract: |
Leiutis puudutab levosimendani lahuste farmatseutilist kasutamist, ja eriti veenisisest manustamist. Leiutisele vastavad lahused on kõrge stabiilsusega ja eriti tõhusad infusiooni- või süstimislahustena või infusioonikontsentraatidena. Levosimendan on tõhus kongestiivse südamerikke ravis.
|
English abstract: |
The invention relates to levosimendan solutions for pharmaceutical use, and particularly for intravenous administration. The solutions of the invention have enhanced stability and they are particularly useful as infusion or injection solutions or infusion concentrates. Levosimendan is useful in the treatment of congestive heart failure.
|
Applicant/holder: |
Orion Corporation
|
Inventor name: |
Reijo Bäckström (FI) Päivi Granvik (FI) Ritva Haikala (FI) Sirpa Pelttari (FI) Eva Saukko (FI) Reija Yrjölä (FI)
|
Drawing(s): Click on the drawing to display a larger drawing!
|
|
Published patent application:
|
Display the published patent application (Document A) |
Patent specification:
|
Display patent specification (Document B)
|
Patent attorney: |
|
|
|
Display: |
DATA OF THE FEES |